Renaissance Technologies LLC Raises Stock Position in Nektar Therapeutics (NASDAQ:NKTR)
Renaissance Technologies LLC grew its position in shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) by 17.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,910,786 shares of the biopharmaceutical company’s stock after buying an additional 583,153 shares during the quarter. Renaissance […]
Renaissance Technologies LLC grew its position in shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) by 17.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,910,786 shares of the biopharmaceutical company’s stock after buying an additional 583,153 shares during the quarter. Renaissance […]
